Epitel’s $26m bet could take weeks-long wireless EEG monitoring beyond specialist centres
Epitel’s $26 million Series B will expand REMI wireless EEG monitoring, provider adoption and ambulatory seizure detection across the United States.
Medical Devices & Diagnostics